Authors' Reply to the Letter "Reevaluating the Role of Demographic and Etiological Factors in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma"

YU-YUN SHAOAndrei Akhmetzhanov2025-11-032025-11-032025-07-05https://scholars.lib.ntu.edu.tw/handle/123456789/733358enDemographicsEtiologyHepatocellular carcinomaImmunotherapyPrognosisTargeted therapy[SDGs]SDG3Authors' Reply to the Letter "Reevaluating the Role of Demographic and Etiological Factors in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular Carcinoma"journal article10.1159/00054729441063732